Skip to main content
Premium Trial:

Request an Annual Quote

Publication of Human Genome Papers Prompts Debate over Assemblies


As expected, last week’s simultaneous publication of Celera’s and the Human Genome Project’s sequencing papers sparked a flurry of debate over the relative strength of the two assembly methods and the quality of the resulting data.

Proponents of the public effort were quick to point out that Celera relied much more heavily upon data from the Human Genome Project than it had originally claimed, and that the bulk of the analysis in Celera’s Science paper was derived from its compartmentalized shotgun assembly rather than its whole genome assembly.

Some interpreted Celera’s shift toward compartmentalized shotgun assembly as proof that whole genome sequencing failed to live up to the company’s claims.

Celera, however, downplayed its use of the public data in its final analysis. “Whole genome shotgunning has been an unqualified success,” said Gene Myers of Celera at the press conference marking the occasion. Other Celera proponents have said that the company’s data is more accurate and of better quality.

Rather than delve any further into the fracas, BioInform has provided a comparison of the two assemblies in the hope that the numbers will speak for themselves.

These figures are based on data reported in the Science and Nature papers, and are not intended to represent the current contents of either Celera’s or the Human Genome Project’s databases.

The genome data available for free on Celera’s website ( remain fixed at the October 1, 2000, point described in its paper, while it will continue to update its subscription-only database. The company has not announced a finish point for its version of the genome sequence.

The Human Genome project said it intends to complete its annotation of the human genome by 2003.

The primary source data available in three public databases — Genbank, EMBL and DDBJ — will be updated continuously as the project moves forward.


File Attachments

Filed under

The Scan

Study Points to Tuberculosis Protection by Gaucher Disease Mutation

A mutation linked to Gaucher disease in the Ashkenazi Jewish population appears to boost Mycobacterium tuberculosis resistance in a zebrafish model of the lysosomal storage condition, a new PNAS study finds.

SpliceVault Portal Provides Look at RNA Splicing Changes Linked to Genetic Variants

The portal, described in Nature Genetics, houses variant-related messenger RNA splicing insights drawn from RNA sequencing data in nearly 335,700 samples — a set known as the 300K-RNA resource.

Automated Sequencing Pipeline Appears to Allow Rapid SARS-CoV-2 Lineage Detection in Nevada Study

Researchers in the Journal of Molecular Diagnostics describe and assess a Clear Labs Dx automated workflow, sequencing, and bioinformatic analysis method for quickly identifying SARS-CoV-2 lineages.

UK Team Presents Genetic, Epigenetic Sequencing Method

Using enzymatic DNA preparation steps, researchers in Nature Biotechnology develop a strategy for sequencing DNA, along with 5-methylcytosine and 5-hydroxymethylcytosine, on existing sequencers.